Pharmaceuticals - 2d Quarter, 1999
| Name |
City |
State |
Amount |
Financing |
Description |
Investors |
| CPBD Inc. |
Cambridge |
MA |
$2,000,000 |
First |
Compound profiling utilizing proprietary patented, immobilized artificial membranes. |
Oxford Bioscience Partners, S.R. One Ltd. |
| eNOS Pharmaceuticals |
Cambridge |
MA |
$2,250,000 |
First |
Innovative treatments for stroke and other central nervous system disorders. |
Essex Woodlands Health Ventures LP, Polaris Venture Partners |
| Infimed Therapeutics Inc. |
Cambridge |
MA |
$8,000,000 |
First |
Develops sustained release formulations of proven and other protein pharmaceuticals, including human growth hormone. |
CHL Medical Partners LP, Prism Venture Partners II LP |
| Pentose Development Corporation |
Cambridge |
MA |
$5,000,000 |
Initial/Seed |
Pharmaceutical development. |
Ampersand Ventures |
| Periodontix Inc. |
Watertown |
MA |
$1,450,000 |
Bridge |
Develops innovative antimicrobial agents and delivery systems to prevent and treat periodontal disease and other chronic infections. |
Benefit Capital, Boston University Community Technology Fund, Child Health Investment Corporation, European Medical Ventures, Landmark Ventures Inc., New Medical Technologies, Technology Funding Venture Partners, and others |
| |
|
|
$18,700,000 |
|
|
0 |
|
Venture capital recipients in New England, by industry, canvassed as part of
the second-quarter 1999 Boston Globe/PricewaterhouseCoopers Money Tree Survey
|
|
|
